We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Procter & Gamble's a Promising Investment Option
Read MoreHide Full Article
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, appears to be a solid bet, given its sturdy efforts to remain on growth trajectory. We expect the company to continue gaining from ongoing initiatives to improve productivity. The company is on track to improve product portfolio through strategic initiatives. Also, it is progressing well with its cost-saving plans.
All these factors helped the company to deliver robust second-quarter fiscal 2020 results. The company’s bottom line beat the Zacks Consensus Estimate, maintaining the positive surprise trend of more than a couple of years. Results primarily gained from productivity efforts, robust shipment volume, favorable mix and pricing. Backed by strong organic sales growth, core earnings and returns to shareholders in the fiscal second quarter, the company also raised its view for fiscal 2020.
The company now projects all-in and organic sales growth of 4-5% compared with 3-5% mentioned earlier. The guidance includes a modest impact of adverse foreign currency, which is likely to be offset by slight gain from acquisitions and divestitures. Moreover, it now projects core EPS growth of 8-11% for fiscal 2020 compared with 5-10% mentioned earlier.
In the past six months, shares of this Cincinnati, OH-based company have increased 8.8%, outperforming the industry’s growth of 6.1%.
Further, analysts are steadily growing bullish on the Zacks Rank #2 (Buy) stock. The Zacks Consensus Estimate for fiscal 2020 and 2021 has moved north by 5 cents each to $4.99 and $5.29, respectively, in the past 30 days.
Factors Narrating Procter & Gamble’s Growth Story
P&G is focused on productivity and cost-saving plans to boost margins. The company’s continued investment in business, alongside efforts to offset macro cost headwinds and balance top-line and bottom-line growth, underscore its productivity efforts.
With cost savings and efficiency improvements across all facets of business, it has crossed the mid-point of its second five-year (fiscal 2017-2021) cost-saving target of $10 billion. The second five-year restructuring plan targets cutting costs in areas including supply chain and cost of goods sold (COGS), marketing, digitization and promotional spend effectiveness.
Also, the company focuses on improving its product portfolio through initiatives, which enable it to concentrate on its fast-growing businesses. For this, it relies on the strategy of acquiring complementary businesses. In a bid to boost its women’s care portfolio, it recently agreed to acquire a growing female body care company – Billie Inc.
The transaction is likely to be complementary to P&G’s existing female grooming portfolio, which includes the Venus, Braun and Joy brands. The company expects to benefit by combining its strong digital and direct-to-consumer marketing capabilities and growing range of personal care products with the fresh, digitally-native brand, which appeals to Millennial and Gen Z consumers.
Further, P&G expects Billie’s high-quality, naturals-focused razors and body care products to make its portfolio more dynamic. Some of its other acquisitions include the beauty brand – First Aid Beauty, producer of period products with natural ingredients – This is L., the consumer health business of Germany-based Merck KGaA and Walker & Company Brands. These acquisitions should bolster the company’s product portfolio in various categories. Also, P&G follows a systematic divestiture plan to streamline its portfolio. It has divested several assets over the years as part of portfolio reshaping plan.
We anticipate all aforementioned factors and its robust outlook to help the company remain in investors’ good books.
The Coca-Cola Company (KO - Free Report) has a long-term earnings growth rate of 7.2% and carries a Zacks Rank #2.
Constellation Brands, Inc. (STZ - Free Report) has a long-term earnings growth rate of 8.2%. Currently, it carries a Zacks Rank #2.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Image: Bigstock
Here's Why Procter & Gamble's a Promising Investment Option
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, appears to be a solid bet, given its sturdy efforts to remain on growth trajectory. We expect the company to continue gaining from ongoing initiatives to improve productivity. The company is on track to improve product portfolio through strategic initiatives. Also, it is progressing well with its cost-saving plans.
All these factors helped the company to deliver robust second-quarter fiscal 2020 results. The company’s bottom line beat the Zacks Consensus Estimate, maintaining the positive surprise trend of more than a couple of years. Results primarily gained from productivity efforts, robust shipment volume, favorable mix and pricing. Backed by strong organic sales growth, core earnings and returns to shareholders in the fiscal second quarter, the company also raised its view for fiscal 2020.
The company now projects all-in and organic sales growth of 4-5% compared with 3-5% mentioned earlier. The guidance includes a modest impact of adverse foreign currency, which is likely to be offset by slight gain from acquisitions and divestitures. Moreover, it now projects core EPS growth of 8-11% for fiscal 2020 compared with 5-10% mentioned earlier.
In the past six months, shares of this Cincinnati, OH-based company have increased 8.8%, outperforming the industry’s growth of 6.1%.
Further, analysts are steadily growing bullish on the Zacks Rank #2 (Buy) stock. The Zacks Consensus Estimate for fiscal 2020 and 2021 has moved north by 5 cents each to $4.99 and $5.29, respectively, in the past 30 days.
Factors Narrating Procter & Gamble’s Growth Story
P&G is focused on productivity and cost-saving plans to boost margins. The company’s continued investment in business, alongside efforts to offset macro cost headwinds and balance top-line and bottom-line growth, underscore its productivity efforts.
With cost savings and efficiency improvements across all facets of business, it has crossed the mid-point of its second five-year (fiscal 2017-2021) cost-saving target of $10 billion. The second five-year restructuring plan targets cutting costs in areas including supply chain and cost of goods sold (COGS), marketing, digitization and promotional spend effectiveness.
Also, the company focuses on improving its product portfolio through initiatives, which enable it to concentrate on its fast-growing businesses. For this, it relies on the strategy of acquiring complementary businesses. In a bid to boost its women’s care portfolio, it recently agreed to acquire a growing female body care company – Billie Inc.
The transaction is likely to be complementary to P&G’s existing female grooming portfolio, which includes the Venus, Braun and Joy brands. The company expects to benefit by combining its strong digital and direct-to-consumer marketing capabilities and growing range of personal care products with the fresh, digitally-native brand, which appeals to Millennial and Gen Z consumers.
Further, P&G expects Billie’s high-quality, naturals-focused razors and body care products to make its portfolio more dynamic. Some of its other acquisitions include the beauty brand – First Aid Beauty, producer of period products with natural ingredients – This is L., the consumer health business of Germany-based Merck KGaA and Walker & Company Brands. These acquisitions should bolster the company’s product portfolio in various categories. Also, P&G follows a systematic divestiture plan to streamline its portfolio. It has divested several assets over the years as part of portfolio reshaping plan.
We anticipate all aforementioned factors and its robust outlook to help the company remain in investors’ good books.
3 Other Stocks to Consider
Helen of Troy Limited (HELE - Free Report) presently has an expected long-term earnings growth rate of 8.6% and sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Coca-Cola Company (KO - Free Report) has a long-term earnings growth rate of 7.2% and carries a Zacks Rank #2.
Constellation Brands, Inc. (STZ - Free Report) has a long-term earnings growth rate of 8.2%. Currently, it carries a Zacks Rank #2.
Zacks Top 10 Stocks for 2020
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?
Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.
Access Zacks Top 10 Stocks for 2020 today >>